Codex DNA, Inc. announced the release of the world’s first full-length synthetic genomes for two emerging variants of the SARS-CoV-2 virus.
You Might Also Like
Mission Bio’s New Translocation Analysis Offers Insights into Critical Safety Assessment for Gene-Edited Cell Products
Quanterix To Provide Research Use Access To The P217+Tau Assay Through Quanterix Accelerator Services Laboratory
